During the process of enzymatic inhibition carbamic group binds to the CAS triad in the active site of AChE to release the phenolic counterpart which exhibits therapeutic potential against AD attributed to the antioxidant mediated neuroprotective activities against AD [64]. Here, ACHE is linked to Alzheimer disease.